vs

Side-by-side financial comparison of TPG Mortgage Investment Trust, Inc. (MITT) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

TPG Mortgage Investment Trust, Inc. is the larger business by last-quarter revenue ($20.4M vs $17.6M, roughly 1.2× AVITA Medical, Inc.). TPG Mortgage Investment Trust, Inc. runs the higher net margin — 65.0% vs -66.0%, a 130.9% gap on every dollar of revenue. On growth, TPG Mortgage Investment Trust, Inc. posted the faster year-over-year revenue change (17.7% vs -4.3%). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 9.1%).

TPG Mortgage Investment Trust, Inc. is a real estate investment trust managed by global alternative asset firm TPG. It primarily invests in residential and commercial mortgage-backed securities, performing and non-performing mortgage loans, and other credit-linked real estate assets, with its core market being the United States. It generates returns via net interest income from holdings and strategic asset disposition gains.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

MITT vs RCEL — Head-to-Head

Bigger by revenue
MITT
MITT
1.2× larger
MITT
$20.4M
$17.6M
RCEL
Growing faster (revenue YoY)
MITT
MITT
+21.9% gap
MITT
17.7%
-4.3%
RCEL
Higher net margin
MITT
MITT
130.9% more per $
MITT
65.0%
-66.0%
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
9.1%
MITT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MITT
MITT
RCEL
RCEL
Revenue
$20.4M
$17.6M
Net Profit
$13.3M
$-11.6M
Gross Margin
81.2%
Operating Margin
67.1%
-59.1%
Net Margin
65.0%
-66.0%
Revenue YoY
17.7%
-4.3%
Net Profit YoY
-7.0%
-0.3%
EPS (diluted)
$0.27
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MITT
MITT
RCEL
RCEL
Q4 25
$20.4M
$17.6M
Q3 25
$19.5M
$17.1M
Q2 25
$17.8M
$18.4M
Q1 25
$18.8M
$18.5M
Q4 24
$17.4M
$18.4M
Q3 24
$14.9M
$19.5M
Q2 24
$16.4M
$15.2M
Q1 24
$17.2M
$11.1M
Net Profit
MITT
MITT
RCEL
RCEL
Q4 25
$13.3M
$-11.6M
Q3 25
$20.0M
$-13.2M
Q2 25
$3.9M
$-9.9M
Q1 25
$11.5M
$-13.9M
Q4 24
$14.3M
$-11.6M
Q3 24
$16.6M
$-16.2M
Q2 24
$3.9M
$-15.4M
Q1 24
$20.9M
$-18.7M
Gross Margin
MITT
MITT
RCEL
RCEL
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
MITT
MITT
RCEL
RCEL
Q4 25
67.1%
-59.1%
Q3 25
-53.6%
Q2 25
20.9%
-60.5%
Q1 25
54.6%
-63.9%
Q4 24
76.7%
-54.1%
Q3 24
-70.6%
Q2 24
18.4%
-102.8%
Q1 24
-155.0%
Net Margin
MITT
MITT
RCEL
RCEL
Q4 25
65.0%
-66.0%
Q3 25
102.5%
-77.3%
Q2 25
22.2%
-53.9%
Q1 25
60.9%
-74.9%
Q4 24
82.2%
-63.0%
Q3 24
111.3%
-82.9%
Q2 24
24.0%
-101.3%
Q1 24
121.6%
-168.0%
EPS (diluted)
MITT
MITT
RCEL
RCEL
Q4 25
$0.27
$-0.37
Q3 25
$0.47
$-0.46
Q2 25
$-0.05
$-0.38
Q1 25
$0.21
$-0.53
Q4 24
$0.30
$-0.44
Q3 24
$0.40
$-0.62
Q2 24
$-0.02
$-0.60
Q1 24
$0.55
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MITT
MITT
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$57.8M
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$560.7M
$-16.6M
Total Assets
$8.7B
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MITT
MITT
RCEL
RCEL
Q4 25
$57.8M
$18.2M
Q3 25
$59.0M
$23.3M
Q2 25
$88.7M
$15.7M
Q1 25
$115.5M
$25.8M
Q4 24
$118.7M
$35.9M
Q3 24
$102.5M
$44.4M
Q2 24
$120.9M
$54.1M
Q1 24
$100.3M
$68.2M
Stockholders' Equity
MITT
MITT
RCEL
RCEL
Q4 25
$560.7M
$-16.6M
Q3 25
$559.8M
$-6.7M
Q2 25
$536.4M
$-12.9M
Q1 25
$543.9M
$-4.6M
Q4 24
$543.4M
$4.5M
Q3 24
$540.1M
$12.2M
Q2 24
$533.5M
$23.9M
Q1 24
$539.6M
$32.6M
Total Assets
MITT
MITT
RCEL
RCEL
Q4 25
$8.7B
$56.4M
Q3 25
$9.0B
$63.7M
Q2 25
$7.5B
$58.1M
Q1 25
$7.3B
$69.6M
Q4 24
$6.9B
$79.7M
Q3 24
$7.0B
$81.1M
Q2 24
$7.1B
$87.8M
Q1 24
$6.4B
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MITT
MITT
RCEL
RCEL
Operating Cash FlowLast quarter
$59.6M
$-5.4M
Free Cash FlowOCF − Capex
$-6.1M
FCF MarginFCF / Revenue
-34.7%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
4.48×
TTM Free Cash FlowTrailing 4 quarters
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MITT
MITT
RCEL
RCEL
Q4 25
$59.6M
$-5.4M
Q3 25
$17.4M
$-5.2M
Q2 25
$11.5M
$-10.2M
Q1 25
$12.0M
$-10.3M
Q4 24
$55.8M
$-8.1M
Q3 24
$14.5M
$-7.2M
Q2 24
$13.7M
$-12.8M
Q1 24
$12.0M
$-20.9M
Free Cash Flow
MITT
MITT
RCEL
RCEL
Q4 25
$-6.1M
Q3 25
$-6.2M
Q2 25
$-10.8M
Q1 25
$-10.5M
Q4 24
$-9.7M
Q3 24
$-11.0M
Q2 24
$-15.4M
Q1 24
$-22.0M
FCF Margin
MITT
MITT
RCEL
RCEL
Q4 25
-34.7%
Q3 25
-36.1%
Q2 25
-58.4%
Q1 25
-56.9%
Q4 24
-52.7%
Q3 24
-56.1%
Q2 24
-101.6%
Q1 24
-198.2%
Capex Intensity
MITT
MITT
RCEL
RCEL
Q4 25
3.8%
Q3 25
5.5%
Q2 25
2.8%
Q1 25
1.2%
Q4 24
8.8%
Q3 24
19.2%
Q2 24
17.5%
Q1 24
10.3%
Cash Conversion
MITT
MITT
RCEL
RCEL
Q4 25
4.48×
Q3 25
0.87×
Q2 25
2.92×
Q1 25
1.05×
Q4 24
3.91×
Q3 24
0.87×
Q2 24
3.50×
Q1 24
0.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons